The major histocompatibility complex on the sixth chromosome controls expression of a complex series of cell surface antigens which comprise the human leukocyte antigen (HLA) system. These markers, beyond their im portance in human organ transplantation, have been demonstrated to occur with an increased prevalence in certain disease states. The group of condi tions showing the closest association with specific HLA antigens are the "spondyloarthropathies." These include ankylosing spondylitis (AS), Rei ter's syndrome (RS), psoriatic arthritis (PsA), and the arthritis of inflamma tory bowel disease (AIBD). Clinical and radiographic studies were made of 310 unrelated caucasoid patients with seronegative arthritis. HLA-A, B, C, and DR typing were performed using the m icrodroplet lymphocyte cytotoxicity test. Statistically increased prevalences of A26, B27, and Bw38 were observed, while B27 was associated with spinal involvement regard less of diagnosis (90 percent in AS p <0.0001). Experiments found A26 (23 percent p <0.001) and Bw38 (38 percent p <0.0001) in patients with PsA. Spondyloarthritis patients with spinal involvement who lacked B27 fre quently had B7. The HLA
Introduction
The major histocompatibility complex (MHC) on the sixth chromosome in man controls the expression of the cell surface proteins known as human leukocyte anti gens (HLA) and influences diverse biological functions. Some of these func-tions include humoral and cellular re sponse to antigenic stimulation, graft re jection, complement activation, and pos sibly disease expression. In this review, brief consideration was made of the de velopment of understanding of this com plex system, biochemical and genetic as pects, and a consideration of the possible relationship of the MHC to the occurrence and manifestations of human disease.
The understanding of this complex in man has been greatly facilitated by studies in the mouse, rat, and other ani mals. Striking homology has been ob served between man and animals. This review will emphasize the MHC in man; considerable information concerning the H-2 region in the mouse is available. 16, 21 Four principle regions denoted as A, B, C, D/DR are recognized. Debate con tinues concerning the relationship be tween the D locus and the DR (D related) locus. It seems likely the D and DR loci will be recognized as distinct areas. The antigens of the A, B, C, and DR loci are detected by serological means utilizing a lymphocytotoxicity assay, and the D locus antigens are determ ined by use of homozygous typing cells in a mixed lym phocyte reaction (MLC). The develop ment of understanding of the MHC can best be separated into humoral and cellu lar observations. In the 1950's, antibodies to white cells were recognized to develop during pregnancy and after blood transfu sion. 27 Detection of "leuko agglutination" after mixing of leukocytes and pregnancy sera was imprecise and technically de manding, but identity of these markers in homozygous twins10 and increased preva lence of specific markers in families documented genetic control of the ex pression of the agglutination reaction. 28 A major technical advance was the ad vent of the microlymphocytotoxicity assay which had a more precise end point, cell death, and conserved serological rea gents. 31 The technique utilizes the place ment of 50,000 lymphocytes into indi vidual wells of a plastic microtitre plate. In each well are carefully screened and adsorbed antisera, each to a different HLA anitgen. After addition of screened rabbit complement and a counter stain, the wells are examined for the presence of cytolysis.
The recognition of the DR locus, dis tinct from the ABC loci, was delayed be cause these markers are principally ex pressed on B lymphocytes (monocytes, macrophages, and endothelial cells as well), but not on the more numerous T cells. 34 Anomalous cytotoxic typing reac tions with lymphocytes from patients with chronic lymphatic leukemia with well characterized antisera was an early clue to the existance of B cell alloantigens. An tibodies interfering in the MLC were also described. Reliable separation of B and T cells with isolation from B cell mem branes of glycoproteins distinct from those of the A, B, and C locus led to ac ceptance of the DR locus. Recently, the MB and MT systems have also been de scribed. 22 Debate continues whether anti sera recognizing these new markers are supertypic (because much overlap with DR exists) or distinct.
Despite the use of microtitre plates, the supply of precise reagents in serological testing is an ongoing problem. It is hoped the development of monoclonal antibodies to HLA antigens through hybridom a technology will solve this problem.
Concurrently with serological studies, it was recognized that mixture of lympho cytes from different individuals induced blastogenesis. 6 This sytem known as the two way MLC was subsequently modified by inactivating one donor's lymphocytes with mitomycin or radiation allowing pre cise recognition of which cells were re sponding and which cells were stimulat ing in the cultures4 and the new locus was termed the D locus.2,11 Use of lympho cytes from patients homozygous for D locus antigens aided precision in testing. Storage by freezing of viable lymphocytes is more difficult than storing antibodies lim iting the num ber of laboratories routinely doing D locus typing.
No discussion of these developments would be complete without mention of the eight international workshops held first in 1964 and most recently in 1980. The collaborative efforts involving mas sive worldwide exchange of antisera and cells are unique in the history of science.
These exchanges established an inter nationally accepted definition of reagents allowing comparisons of observations among laboratories particularly important for disease relation studies. Reagents under study prior to final acceptance are denoted by a "w" for workshop.
The biochemical composition of HLA antigens is quite similar in the mouse, rat, and man. Similarity is also noted to im m unoglobulin m olecules. The gene products of the A, B, and C locus are glycoprotein structures consisting of a polymorphic heavy chain with a molecu lar weight of45,000 daltons and a constant light chain of 11,000 daltons known as B2 microglobulin.17 DR antigens are com posed of a 34,000 dalton alpha constant chain and a 29,000 dalton beta B polymor phic chain. 18 Certain of the antigens are quite similar in structure and said to share public determinants. The most important example is the B7 CREG or cross reacting group which includes B7, 22, 27, 40, and 44.
Genetics
Generally the MHC is inherited as a block in dominant fashion. Genetic re combination occurs in less than one per cent of individuals but is useful in locating elem ents of the MHC on the sixth chromosome. 5 The distance betw een genes as determined by the frequency of recombination is expressed as centromorgans (Cm). For example it has been esti mated the distance between HLA A and B is 0.8 to 1 Cm. 17 Another important genetic aspect in the MHC is the occurrence of linkage disequilibrium. This is defined as the occurrence of two HLA antigens to gether more or less frequently than would be predicted by chance. For example, A26 and BW 38 occurred together more often than their individual prevalences in the population m ultiplied together would predict. Some survival advantage of specific combinations of HLA antigens may be the explanation.
The cross products from a 2 X 2 table established from the prevalence of anti gen positive and negative patients and control groups can be used to calculate relative risk RR = (ad/bc) of a patient with a specific antigen developing a specific disease. 34 The term genetic linkage refers to in herited genetic diseases whose expression is controlled entirely genetically as de termined by family studies. Examples of conditions genetically linked to the MHC include 21-hydroxylase deficiency result ing in congenital adrenal hyperplasia and deficiency of the second and fourth com ponent of complement. The term associa tion indicates a genetic predisposition to a disease which requires other non-genetic factors as well for expression. Most of the disease relationships to the MHC are associations.
The first association of the MHC and a human disease was reported in 1967 in Hodgkin's disease patients. Increased prevalence of an early specificity known as 4C was noted.1 It was subsequently shown that the increased prevalence was related to a heightened frequency of B5 in these patients. 15 The weak nature of this association has rendered it controversial and not demonstrable in all series. The prognosis in Hodgkin's has also been re lated to the presence of HLA antigens.14 This requires confirmation but indicates one possible usefulness in determining HLA phenotypes. The majority of HLA associated diseases involve malignancies, infectious diseases, immunologic, and rheumatic diseases. 24 In table I are indi cated the broad range of conditions that appear to have an HLA association.
Antigens in linkage disequilibrium may also have disease associations. One of the most commonly observed is Al, B8, and DRW 3. This combination is frequently observed in "autoimmune" conditions such as myasthenia gravis, chronic active hepatitis, systemic lupus erythematosus, and Graves' disease, among others. The prevalence of the antigens comprising the haplotype may be studied individually in population studies. The antigen with the highest prevalence and greatest relative risk in the disease population is most likely to be the antigen involved in the pathogenesis of the disease. For example, in the "autoimmune" diseases, the closest association is generally observed with DRW 3. This likelihood could be pre dicted from mouse studies which have documented the immune response (IR) region of the H-2 complex which appears to be homologous with the DR locus in man. Another aspect of the association of HLA and systemic lupus erythematosus (SLE) is the recognition of the occurrence of this disease in individuals who lack the second component of complement. 26 The apparent paradox because of com plement involvement in SLE induced in flammation remains unexplained. A locus associations are unusual. The best exam ple is the association of A3 and hemo chromatosis. 8 In table II and III are indicated our re sults in HLA typing spondyloarthritis pa tients in the Tampa, Florida area. In our study, the frequency distribution of the HLA A, B, and C antigens, with the excep tion of A26, B27, Bw38, Cwl, and Cw2, did not differ substantially in the six groups of patients and unaffected controls (table II) . The values for seronegative rheumatoid arthritis and osteoarthritis groups of patients were normal. In the an kylosing spondylitis group, B27 was pres ent in 89.5 percent (77/86) of patients (p < 0.0001). Two of nine patients (22.2 per- In patients with inflammatory bowel disease (IBD) and arthritis, B27 was pres ent in 37.5 percent (p < 0.01). HLA-DR typing was performed in 196 patients. The frequency distribution of the HLA-DR specificities was normal in all groups of 2 0 VASEY, ESPINOZA, BOCANEGRA, AND GERMAIN ♦Significantly different from controls (p < 0.001, and p < 0.015 when corrected for the fifteen specificities tested) tSignificantly different from controls (p < 0 .0 0 0 1 , and p < 0.0018 when corrected for the eighteen specificities tested) $P value < 0 . 0 0 0 1 compared to controls, and p < 0.0018 when corrected for the number of specificities tested §P value < 0.002 compared to controls, and p < 0.01 when corrected for the number of specificities tested /P value < 0 . 0 0 0 1 compared to controls, and p < 0.0006 when corrected for the number of specificities tested HP value < 0.0014 compared to controls, and p < 0.008 when corrected for the number of specificities tested patients except for the psoriatic arthritis group (table III) . DRw4 was present in 52.9 percent (p < 0.03) compared to our controls, and p < 0.003 compared to the Seventh International Histocompatibility Workshop controls, corrected p < 0.02. The specificity of DRw7 was also found in 39 percent of patients (corrected p < 0.04).
Our data indicate that HLA-B27, Bw38, DRw4, and DRw7 antigens are distinctive markers for patients with seronegative spondyloarthritis. The B27 seems to be a highly specific genetic marker for patients with spinal involvement while Bw38 and DRw4 characterize patients with psoriatic arthritis. The closest association between dis ease expression and the MHC occurs in ankylosing spondylitis (AS). The discov ery of the association between AS and B27 was made by two groups independently in 1973.9,30 It is now clear that 90 to 100 per cent of caucasoid individuals with AS will express B27. Black patients, however, have a comparatively decreased preva lence of B27 (50 percent) and an increased prevalence of B7 (30 percent) a related antigen. 19 The B27 also is closely linked as well to the other forms of spondyloarthritis which include psoriatic arthritis (PsA), Reiter's syndrome (RS), and the arthritis of in flammatory bowel disease (AIBD). Gen erally a somewhat lower frequency of B27 (60 to 80 percent) is observed in these related spinal arthropathies.
Psoriasis and PsA are of particular interest for the variety of observed associ ations. Thus, B13, B17, B37, B39, or CW6 occur in approximately 10 to 50 percent of psoriasis without arthritis patients. 29 20 This discrepancy may result from the heterogeneity of DRW4,7 variation in the p atient population studied, or technical factors w ithin laboratories. Concerning the prevalence of B27 in RS and AIBD, our data ex pressed in table II are typical noting B27 in approximately 60 to 80 percent of patients with RS and AIBD. The DR locus associa tions do not seem to be important in AS, RS, and AIBD.
Presently studies are directed at resolv ing the question concerning how the MHC is related to disease expression. A number of suggestions have been made. These include "molecular mimicry" in which the structure of an environmental pathogen mimics that of the HLA antigen allowing the pathogen to induce disease. The HLA antigen may act as a receptor for the disease causing agent. The HLA anti gen itself may not be important, but it may be closely linked to a yet undiscovered immune response or disease causing gene. Better understanding of complex re lationships among the MHC, immune re sponse, and disease expression may lead to precise genetic, immunological, or en vironmental manipulation to paliate or prevent many of today's diseases.
